The Centers for Medicare and Medicaid Services has granted a temporary New Technology Add-on Payment for glucarpidase [Voraxaze]
Source: Reactions Weekly, Volume 1, Number 1419, 2012-09-15 , pp. 5-5(1)
Publisher: Adis International
Keywords: Drug-toxicity, treatment; Drug-toxicity, drug-induced; Glucarpidase, therapeutic use; Methotrexate, adverse reactions; Reimbursement
Document Type: Short communication
Publication date: 2012-01-01
- In this: publication
- By this: publisher
- In this Subject: Pharmacology

Shopping cart
Receive new issue alert
Get Permissions